bioRxivBioengineeringPreprint
Immune reprogramming of 3D tumor models via optoporation-mediatedtargeted gene delivery to macrophages
Ines PoljakiD, Izzah Nabilah Hussein, Chenlei GuiD, Giulio GiustariniiD, Xiang TengiD, Yusuke ToyamaiD, Ciro ChiappiniiD, Giulia AdrianiiD
Abstract
The dynamics of the tumor microenvironment (TME) are a key determinant of cancer progression and therapeutic resistance through complex interactions between tumor, stromal and immune cell populations. Among these, tumor-associated macrophages (TAMs) play a central role in promoting tumor growth and immune suppression. However, the specific contributions of TAMs remain poorly understood due to the lack of tools enabling selective genetic manipulation in three-dimensional (3D) tumor models. Here, we present a gold nanoparticle-assisted optoporation approach that enables spatially selective plasmid-based gene delivery to TAMs within intact heterocellular 3D pancreatic ductal adenocarcinoma (PDAC) spheroids, thereby modulating the TME. In two-dimensional (2D) TAM cultures, conventional transfection of IRF5- and IKBKB-encoding plasmids validated their capacity to induce TAM repolarization, as evidenced by activation of interferon signaling. Extending this approach to 3D PDAC spheroids, nanoparticle-assisted optoporation achieved selective transfection of TAMs with IRF5- and IKBKB-encoding plasmids by transiently generating nanoscale membrane pores in illuminated cells. TAMs transfection elicited a robust interferon response, marked by transcriptional upregulation of IFNA, IFNB1, and CXCL10, and increased protein levels of IFNB1, IFNL1, and CXCL13, together with downregulation of pro-tumorigenic markers CEACAM5, IL19, and IL32. These coordinated changes indicate a shift towards an anti-tumorigenic TME. By enabling minimally invasive, TAM-specific gene delivery in complex multicellular 3D spheroids, this strategy allows precise modulation of the TME and opens new avenues for modeling its dynamics in cancer progression and therapeutic response.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting human M2 macrophages with antibodies in optimized 3D tumor spheroids
Chloe Bazile, Fabien Gava, … Mary Poupot·bioRxiv·Sep 16, 2025
- The Immune Landscape of Tumor-Associated Macrophage Reprogramming
Florent Duval, João Lourenço, … Nahal Mansouri·bioRxiv·Sep 25, 2024
- Macrophage proliferation machinery leads to PDAC progression, but susceptibility to innate immunotherapy.
D. G. DeNardo, C. Zuo, … J. D. Weber·bioRxiv·Nov 8, 2021
- Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression
Y. Bi, V. S. Shirure, … R. C. Fields·bioRxiv·May 27, 2020
- An Engineered 3D Co-culture Model of Primary Macrophages and Patient-Derived Tumour Cells to Explore Cellular Responses in the Graded Hypoxic Microenvironment of Pancreatic Cancer
I. L. Co, C. Yu, … A. P. McGuigan·bioRxiv·Jul 13, 2023
- Targeting macrophages with CAR-T cells delays solid tumor progression and enhances anti-tumor immunity
A. R. Sanchez-Paulete, J. Mateus-Tique, … B. D. Brown·bioRxiv·Dec 17, 2021